A new study has revealed that the widely prescribed Parkinson's disease drug entacapone significantly disrupts the human gut microbiome by inducing iron deficiency. The findings, published in ...

Expert Rev Neurother. 2009;9(7):929-940. Improvements in levodopa pharmacokinetics with the addition of entacapone were similar to that seen in healthy volunteers. In addition, Phase II trials ...

treatment of PD using the catechol-O-methyl transferase inhibitor entacapone with carbidopa/levodopa improves quality of life and activities of daily living. In fluctuating PD patients ...